Advertisement
The company will hold a conference call to discuss its financial resultsand operating activities to all interested parties at 1:30 p.m., PacificDaylight Time (4:30 p.m., Eastern Daylight Time), Thursday, July 31, hosted byGary F. Burbach, president and chief executive officer, and David Smith,executive vice president and chief financial officer.
Advertisement
The teleconference can be accessed by calling (913) 312-0379, passcode4566478. Please dial in 10-15 minutes prior to the beginning of the call. Thewebcast will be available on the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=1890100 or athttp://www.thoratec.com
A replay of the conference call will be available through Thursday,August 7, via http://www.thoratec.com or by telephone at (719) 457-0820,passcode 4566478.
Thoratec Corporation is a world leader in therapies to addressadvanced-stage heart failure. The company's product lines include theThoratec(R) VAD (Ventricular Assist Device) and HeartMate (R) LVAS (LeftVentricular Assist System) with nearly 12,000 devices implanted in patientssuffering from heart failure. Additionally, its International TechnidyneCorporation (ITC) division supplies point-of-care blood testing and skinincision products. Thoratec is headquartered in Pleasanton, California. Formore information, visit the company's web sites at http://www.thoratec.com orhttp://www.itcmed.com
SOURCE Thoratec Corporation
